chr19-44703427-T-A
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 1P and 5B. PP3BP6BS1
The NM_001039213.4(CEACAM16):c.116T>A(p.Leu39Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000483 in 1,613,712 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. L39L) has been classified as Uncertain significance.
Frequency
Consequence
NM_001039213.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001039213.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CEACAM16 | NM_001039213.4 | MANE Select | c.116T>A | p.Leu39Gln | missense | Exon 3 of 7 | NP_001034302.2 | ||
| CEACAM16-AS1 | NR_186815.1 | n.348-4250A>T | intron | N/A |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CEACAM16 | ENST00000587331.7 | TSL:1 MANE Select | c.116T>A | p.Leu39Gln | missense | Exon 3 of 7 | ENSP00000466561.1 | ||
| CEACAM16 | ENST00000405314.2 | TSL:5 | c.116T>A | p.Leu39Gln | missense | Exon 2 of 6 | ENSP00000385576.1 | ||
| CEACAM16-AS1 | ENST00000590796.1 | TSL:5 | n.315-4250A>T | intron | N/A |
Frequencies
GnomAD3 genomes AF: 0.000230 AC: 35AN: 152198Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000724 AC: 18AN: 248778 AF XY: 0.0000888 show subpopulations
GnomAD4 exome AF: 0.0000294 AC: 43AN: 1461514Hom.: 0 Cov.: 32 AF XY: 0.0000275 AC XY: 20AN XY: 727056 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000230 AC: 35AN: 152198Hom.: 0 Cov.: 32 AF XY: 0.000269 AC XY: 20AN XY: 74360 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
The p.Leu39Gln variant in CEACAM16 has not been previously reported in individua ls with hearing loss, but has been identified in 0.08% (20/23988) of African chr omosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitut e.org/; dbSNP rs375722926). Although this variant has been seen in the general p opulation, its frequency is not high enough to rule out a pathogenic role. Compu tational prediction tools and conservation analysis do not provide strong suppor t for or against an impact to the protein. In summary, the clinical significanc e of the p.Leu39Gln variant is uncertain. ACMG/AMP criteria applied: None
not provided Benign:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at